Intangible Assets and Goodwill

12 Months Ended

Dec. 29, 2017

Goodwill And Intangible Assets Disclosure [Abstract]

Note 5 – Intangible Assets and Goodwill

Definite-lived intangible assets consist of the following:

	December 29, 2017
	Gross value		Accumulated amortization			Accumulated impairment charges		Carrying amount		Weighted average useful life
Trademarks	$	9,690	$	(5,814	)	$	—	$	3,876	10.0 years
Customer relationships		81,427		(20,060	)		—		61,367	7.8 years
Developed technology		22,990		(14,938	)		—		8,052	7.7 years
Backlog		660		(550	)		—		110	0.5 years
Total intangible assets	$	114,767	$	(41,362	)	$	—	$	73,405

	December 30, 2016
	Gross value		Accumulated amortization			Accumulated impairment charges			Carrying amount		Weighted average useful life
Trademarks	$	9,690	$	(4,845	)	$	—		$	4,845	10.0 years
Customer relationships		50,557		(17,150	)		(11,076	)		22,331	10.0 years
Developed technology		28,100		(14,975	)		(8,155	)		4,970	6.9 years
Backlog		30		(30	)		—			—	0.5 years
Total intangible assets	$	88,377	$	(37,000	)	$	(19,231	)	$	32,146

Amortization expense totaled $8.9 million, $7.0 million, and $6.9 million during 2017, 2016, and 2015, respectively.

Future projected annual amortization expense consists of the following:

	Future amortization expense
2018	$	15,198
2019		12,604
2020		12,604
2021		12,570
2022		8,792
Thereafter		11,637
	$	73,405

The following tables present the changes to goodwill:

	Goodwill
Balance at December 26, 2014	$	70,015
Acquisitions		—
Impairment		—
Balance at December 25, 2015		70,015
Acquisitions		7,078
Impairment		—
Balance at December 30, 2016		77,093
Acquisitions		92,306
Impairment		—
Balance at December 29, 2017	$	169,399

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details